{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T21:12:31Z","timestamp":1700341951675},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.transci.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T12:09:48Z","timestamp":1557490188000},"page":"491-494","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit"],"prefix":"10.1016","volume":"58","author":[{"given":"Jiajia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Pavenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2019.05.003_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0042-9007.2004.00391.x","article-title":"Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on","volume":"86","author":"Bierling","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2019.05.003_bib0010","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.05.003_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00277-015-2304-4","article-title":"The Canadian Choosing Wisely campaign: the Canadian Hematology Society\u2019s top five tests and treatments","volume":"94","author":"Hillis","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.transci.2019.05.003_bib0020","series-title":"Intravenous immune globulin (IVIG) 2012 audit report","author":"Network ORBC","year":"2012"},{"key":"10.1016\/j.transci.2019.05.003_bib0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/tme.12391","article-title":"Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres","volume":"27","author":"Shih","year":"2017","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2019.05.003_bib0030","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.05.003_bib0035","series-title":"Transfusion transmitted injuries surveillance system user\u2019s manual version 3.0","year":"2007"},{"key":"10.1016\/j.transci.2019.05.003_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V72.1.121.121","article-title":"Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin","volume":"72","author":"Bussel","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.05.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142217","article-title":"Corticosteroid risk function of severe infection in primary immune thrombocytopenia adults. A nationwide nested case-control study","volume":"10","author":"Moulis","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2019.05.003_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2019.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.clinthera.2009.05.006","article-title":"Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura","volume":"31","author":"Xie","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.transci.2019.05.003_bib0060","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transci.2019.05.003_bib0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.1999.01766.x","article-title":"Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g\/kg b.w","volume":"107","author":"Godeau","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.05.003_bib0070","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V82.5.1415.bloodjournal8251415","article-title":"Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin","volume":"82","author":"Godeau","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.05.003_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MBC.0b013e3283401490","article-title":"The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials","volume":"21","author":"Qin","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.transci.2019.05.003_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(87)90546-8","article-title":"Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults","volume":"83","author":"Kurlander","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.transci.2019.05.003_bib0085","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/j.1537-2995.2007.01400.x","article-title":"Intravenous immunoglobulin utilization in the canadian Atlantic provinces: a report of the atlantic collaborative intravenous immune globulin utilization working group","volume":"47","author":"Constantine","year":"2007","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218303872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218303872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T21:18:03Z","timestamp":1574630283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050218303872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1473050218303872"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.05.003","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}